Wed.Oct 23, 2024

article thumbnail

Scientists used infrared light to create artificial vision in patients with vision loss

STAT

Science Corporation published preliminary data from a late stage, multi-center clinical trial of a retinal implant that showed promising results Tuesday. Using this prosthetic, scientists partially restored vision to people whose central visual field has holes or blurry spots. Trial participants could read text and recognize playing cards when using the implant, even though they were legally blind.

337
337
article thumbnail

Dengue is spreading and Sanofi is pulling the market’s only vaccine. What’s next?

PharmaVoice

As Sanofi prepares to halt production on its dengue vaccine in 2026, locally acquired infections in the U.S. are raising the alarm.

Vaccines 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study challenges finding that Black babies are more likely to survive under the care of Black physicians

STAT

New research calls into question the high-profile conclusion of the first major study to show that the race of physicians influences health outcomes.  In August of 2020, a study published in the Proceedings of the National Academies of Science made headlines with its finding that Black infants were half as likely to survive to their first birthday when they were cared for by white doctors instead of Black ones.

350
350
article thumbnail

Trick of the Trade: Cut IV extension tubing for 2-person ultrasound guided nerve block

ALiEM - Pharm Pearls

Ultrasound-guided procedures are difficult enough just identifying the anatomy. Performing a nerve block with the ultrasound in one hand and the needle in the other hand adds extra challenges. The simplest 1-person approach involves attaching a syringe with local anesthetic directly to the end of the procedural needle. A 2-person approach involves attach the syringe to a custom tubing-needle setup such as below.

141
141
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Frustrated with Change Healthcare breach, senators propose removing limits on HIPAA fines

STAT

Linda Barbour thought she was more interested in the Change Healthcare cyberattack than most. Having worked as a medical director for several large health insurance companies and having suffered through the Change fiasco herself as a rehab doctor with a private practice in Kansas City, she figured that if her data had been exposed in that February breach, she would have been notified by now.

HIPAA 330
article thumbnail

Pharmacy opening times cut by more than three million hours a year, CCA claims

The Pharmacist

An estimated 3.4 million hours of community pharmacy access is lost in England each year due to under-pressure premises reducing their opening hours, the Company Chemists' Association (CCA) has claimed. This is based on analysis of the Consolidated Pharmaceutical List that shows a net loss of almost 64,000 pharmacy weekly opening hours between September 2022 […] The post Pharmacy opening times cut by more than three million hours a year, CCA claims appeared first on The Pharmacist.

More Trending

article thumbnail

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

pharmaphorum

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by these manufacturers.

article thumbnail

More state Medicaid programs consider covering GLP-1 drugs

STAT

Most state Medicaid programs don’t cover the new class of weight loss drugs for obesity, but that could soon change. Half of those that don’t are considering adding coverage, per a new KFF report.  While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs for obesity.

Diabetes 333
article thumbnail

Norovirus vaccine trial to launch in the UK

The Pharmacist

A randomised clinical trial of an mRNA vaccine against norovirus will be launched in the UK within the next two weeks, it has been announced. It will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403, which if successful could be the first licensed norovirus vaccine in the world. The trial is […] The post Norovirus vaccine trial to launch in the UK appeared first on The Pharmacist.

Vaccines 109
article thumbnail

STAT+: U.K.’s cost-effectiveness agency says Alzheimer’s drug donanemab does not provide good value

STAT

LONDON — For the second time in a matter of months, the U.K.’s cost-effectiveness watchdog has said the limited benefits of a newly approved Alzheimer’s drug do not justify its costs, threatening the possibility of the medicine reaching patients. The National Institute for Health and Care Excellence said in draft guidance released Wednesday that the drug, Eli Lilly’s donanemab, “cannot currently be considered good value for the taxpayer,” given the

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

U.S. FDA approves Pfizer's RSV vaccine ABRYSVO® for adults aged 18 to 59 at increased risk for disease

World Pharma News

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of lower respiratory tract disease (LRTD) caused by RSV in individuals 18 through 59 years of age who are at increased risk for LRTD caused by RSV.

Vaccines 119
article thumbnail

STAT+: Morning Rounds: Study on racial health disparities called into question

STAT

Does anyone here listen to Who Weekly? They sort celebrities into “Whos” (the not-as-famous) and “Thems” (the universally-well-known). So, like: RFK is a Them, while Casey and Calley Means are Whos. The study below on sense of smell and breathing made me think: What’s the Who-to-Them ranking of the five senses? First I thought smell was the Whoiest, but my editor wisely suggested touch as the sense people most often forget.

267
267
article thumbnail

Concerns over resourcing as SMRs recommended to prevent falls

The Pharmacist

Pharmacy teams must be supported to prioritise structured medication reviews (SMRs), particularly for patients at risk of falls, the Royal Pharmaceutical Society (RPS) has stressed. This comes as new draft guidelines from NICE suggest that SMRs should be used to identify any medicines that increase the risks of falls and how they may be adjusted. […] The post Concerns over resourcing as SMRs recommended to prevent falls appeared first on The Pharmacist.

101
101
article thumbnail

STAT+: What’s on the docket for Congress post-election: Chinese biotech, Medicare payments, ACA subsidies

STAT

WASHINGTON — When Congress returns on Nov. 12 after the elections, lawmakers will have just over a month to fund the government.  That deadline pressure creates an opportunity to potentially enact health care legislation. Regardless of what happens this year, next year will be huge for health care policy, in part because lawmakers need to address major expiring policies.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Rise of almost untreatable superbug linked to a common antibiotic

The Guardian - Pharmaceutical Industry

‘Surprising’ finding by Australian-led study is first recorded instance of one antibiotic causing resistance to another in a different class Follow our Australia news live blog for latest updates Get our breaking news email , free app or daily news podcast The rise of an almost untreatable superbug has been linked to a common antibiotic, an Australian-led study has found.

104
104
article thumbnail

Wojcicki projects confidence amid 23andMe stumbles

STAT

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Good morning. It’s been a while since I shared some local news: Chicago has yet again proved itself not only to be the best, but also the rattiest city in the U.S.

article thumbnail

The power of patient insights in shaping successful drug development

pharmaphorum

Patient insights play a critical role in shaping successful drug development. Learn how understanding the needs and experiences of patients can drive innovation and improve outcomes in the pharmaceutical industry.

article thumbnail

STAT+: Pharmalittle: We’re reading about Novo targeting compounded obesity drugs, an Amgen ‘at risk’ launch, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

What Does the FDA's Recent Update of the Nitrosamine Guidance Convey?

PharmaTech

This article presents an overview of FDA’s recent update to the guidance document, Control of Nitrosamine Impurities in Human Drugs.

article thumbnail

BASF introduces Pepsensyal Peptide for slow-aging skin care solutions

Express Pharma

BASF’s Personal Care business has launched a new synthetic peptide, Pepsensyal, designed for skin care applications. Inspired by the skin’s natural regenerative process, Pepsensyal has been clinically proven to reduce and delay the first visible signs of ageing. This new ingredient addresses the slow-ageing trend, reflecting a shift in consumer attitudes towards embracing healthy ageing rather than attempting to counteract the natural ageing process.

103
103
article thumbnail

Unlocking impact and growth at times of demerger

pharmaphorum

Discover strategies for unlocking impact and driving growth during times of demerger in the pharma and medtech industries. Learn key insights and best practices for navigating this critical transition successfully.

97
article thumbnail

Uhlmann India inaugurates new office and showcases blister packaging solutions

Express Pharma

Uhlmann India inaugurated its new office on October 16th at Chakan MIDC Phase II in Pune, Maharashtra. This event marked a significant step in the company’s growth and commitment to Indian operations. The ceremony was attended by industry figures, including Sundeep Bambolkar, Joint Managing Director of Indoco Remedies, and Anil Arora, President of Global Manufacturing Operations at Granules India.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

A slow start for self-amplifying mRNA vaccines

Pharmaceutical Technology

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

Vaccines 105
article thumbnail

Pfizer gets a leg up in RSV as FDA clears jab for all adults

pharmaphorum

A new FDA approval has given Pfizer a broader label for its respiratory syncytial virus (RSV) vaccine Abrysvo than rival shots from GSK and Moderna, but it may not make much of a difference in the battle for market share.The US regulator has cleared Abrysvo for use in adults aged 18 to 59 at risk of RSV-related disease, extending its earlier label which covered the 60 and over age bracket.

Labelling 103
article thumbnail

2024 PharmaVoice 100s: Biotech Pathfinders

PharmaVoice

Leaders solving biology's toughest puzzles and driving innovation forward.

130
130
article thumbnail

Creating True Value with GenAI

pharmaphorum

Unlock the true value of GenAI technology with Axtria's innovative solutions. Learn how to leverage GenAI for your business success.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Using Google Patents to Find Drug Patents? Here’s 15 Reasons Why You Shouldn’t

Drug Patent Watch

When it comes to patent searches, especially in the pharmaceutical industry, accuracy and comprehensiveness are crucial. While Google Patents is a popular tool due to its accessibility and user-friendly interface, it may not be the best resource for finding drug patents. Let’s explore why.

82
article thumbnail

Lawmakers seek answers on Pfizer, Lilly telehealth moves

pharmaphorum

US lawmakers fear Pfizer and Lilly's recent forays into direct-to-consumer distribution of medicines via telehealth could violate anti-kickback laws.

111
111
article thumbnail

J&J’s Darzalex combination gains expanded label for multiple myeloma in Europe

Pharmaceutical Technology

Darzalex will now be available to patients with newly diagnosed multiple myeloma eligible for autologous stem cell transplant.

article thumbnail

Asahi Kasei Medical launches Planova FG1 next-generation virus removal filter

Express Pharma

Asahi Kasei Medical has introduced its latest innovation, the Planova FG1 virus removal filter, to enhance the efficiency and safety of biopharmaceutical manufacturing. The company’s bioprocess business includes Planova virus removal filters and equipment used in the production of biotherapeutic products, such as biopharmaceuticals and plasma derivatives, biosafety testing services, and biopharmaceutical contract development and manufacturing operations.

85
article thumbnail

UK 'should abolish clock changes on health grounds'

pharmaphorum

On Sunday, the clocks in the UK will be set back by an hour as British Summer Time ends, and some believe the practice of twice-yearly changes could impact our health.Many will celebrate having an extra hour in bed – perhaps forgetting how they lost an hour at the end of March when the clocks went forward – but the British Sleep Society (BSS) is advocating for the changes to be abolished altogether and for the UK to return to Standard or Greenwich Mean Time (GMT).

85